Affiliate files Form 144 to sell 2,910 shares

Christopher Patusky filed a Form 144 to sell 2,910 shares via stock option exercise on 04/24/2026.

Rhea-AI Filing Summary

Christopher Patusky filed a Form 144 to sell 2,910 shares via stock option exercise on 04/24/2026.

The notice lists the sale method as a Stock Option Exercise through Morgan Stanley Smith Barney LLC on 04/24/2026. The excerpt also reports a prior sale of 1,000 shares on 04/17/2026 for $578,880.00.

Insights

Corporate Governance Analyst

Routine affiliate resale notice tied to an option exercise; limited market signal.

The filing is a Section 144 notice showing a planned sale of 2,910 shares via a stock option exercise, with execution through Morgan Stanley Smith Barney LLC on 04/24/2026. Such notices are procedural disclosures required when affiliates propose to sell restricted or control securities.

Because the filing lists a prior sale of 1,000 shares on 04/17/2026 for $578,880.00, subsequent trading activity and transaction details in broker reports will determine actual market impact. Timing and proceeds treatment are stated as a stock option exercise; cash‑flow recipient is the issuer per the excerpt.

Key Figures

Shares proposed to be sold: 2,910 shares Prior shares sold: 1,000 shares Value of prior sale: $578,880.00 +1 more

4 metrics

Shares proposed to be sold 2,910 shares Stock Option Exercise on 04/24/2026

Prior shares sold 1,000 shares Sold on 04/17/2026

Value of prior sale $578,880.00 Proceeds reported for 1,000-share sale on 04/17/2026

Filing date 04/24/2026 Form 144 sale notice date

Key Terms

Form 144, Stock Option Exercise, Issuer, NASDAQ

4 terms

Form 144 regulatory

"Filed to give notice of proposed sale of restricted securities"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Stock Option Exercise financial

"Method listed for the securities to be sold on 04/24/2026"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

Issuer financial

"Sale method shows 'Issuer' as counterparty for the exercise proceeds"

NASDAQ market

"Exchange listed alongside the securities and dates"

The Nasdaq is a stock exchange where many companies' shares are bought and sold, functioning much like a marketplace for investments. It matters to investors because it provides a platform to buy and sell ownership stakes in companies, helping them track the value of those companies and make informed decisions. As one of the largest and most technology-focused markets, it also reflects trends and developments in the business world.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does UTHR Form 144 filed by Christopher Patusky disclose?

The Form 144 discloses a proposed sale of 2,910 shares via a stock option exercise on 04/24/2026. It also notes a prior sale of 1,000 shares on 04/17/2026 for $578,880.00.

Who is handling the sale shown on the UTHR Form 144?

The sale is being handled through Morgan Stanley Smith Barney LLC, listed as the broker/executive financial services contact for the transaction on 04/24/2026.

What sale method is identified in the UTHR Form 144?

The filing identifies the method as a Stock Option Exercise with proceeds indicated as Cash and the issuer specified in the excerpt as the recipient on 04/24/2026.

How many shares were sold recently before the Form 144 filing?

The excerpt reports a sale of 1,000 shares on 04/17/2026 valued at $578,880.00, recorded under the seller name Christopher Patusky.

Does the Form 144 list the exchange for the securities?

Yes, the excerpt lists NASDAQ as the market/exchange associated with the securities in the filing dated 04/24/2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/24/2026 - 04:01 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001231427
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	UNITED THERAPEUTICS CORPORATION
SEC File Number	000-26301
Address of Issuer	1000 SPRING STREET SILVER SPRING MARYLAND 20910
Phone	(301) 608-9292
Name of Person for Whose Account the Securities are To Be Sold	CHRISTOPHER PATUSKY
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	2910	1655790.00	43827686	04/24/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/24/2026	Stock Option Exercise	Issuer			2910	04/24/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
CHRISTOPHER PATUSKY 1000 SPRING STREET SILVER SPRING MD 20910	Common	04/17/2026	1000	578880.00

144: Remarks and Signature

Remarks
Date of Notice	04/24/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/18/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Christopher Patusky
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)